Alzheimer's risk increased by 80% in over 65s who have had Covid, claims study Experts are still unclear as to whether Covid can trigger the onset of Alzheimer's or speed its development. Daily Record · Oct 3, 2022
Over-65s twice as likely to develop Alzheimer’s within a year of Covid infection, according to study Researchers from the Case Western Reserve University in Cleveland, Ohio analysed the electronic health records of 6.2 million adults Evening Standard · Oct 3, 2022
Covid warning to everyone aged 66 and above New research has found over 65s who contract covid increase their risk of getting Alzheimer's Liverpool Echo · Oct 3, 2022
Having had Covid can increase risk of Alzheimer's by 80% for some people Researchers aren't certain whether COVID-19 triggers new development of Alzheimer’s disease or accelerates its emergence Wales Online · Oct 3, 2022
Over-65s who had Covid are 80 per cent more likely to develop Alzheimer’s, study reveals It is unclear whether coronavirus triggers new development of the disease or accelerates its emergence The Independent UK · Oct 2, 2022
‘Historic moment’: Drug slows cognitive decline in Alzheimer’s It's being widely reported that an experimental drug has slowed the cognitive decline and brain damage in Alzheimer's patients. The New Daily · Oct 1, 2022
These Stocks Are On The Radar After Biogen-Eisai's Surprising Alzheimer's Trial Win Eli Lilly And Co (NYSE:LLY) - Market cap: $295 billion. Benzinga · Sep 28, 2022
Drug shown to slow memory decline in Alzheimer's patients in 'historic' breakthrough Alzheimer's Research UK said this is the first later-stage trial of an Alzheimer's drug 'in a generation' to successfully slow cognitive decline Wales Online · Sep 28, 2022
Alzheimer's drug is world's first shown to slow symptoms in 'historic' breakthrough The success of an experimental drug offers new hope to people affected by the cruel disease. Daily Record · Sep 28, 2022
‘Historic’ breakthrough as dementia drug shown to slow cognitive decline Lecanemab found to slow decline in participants’ memory and thinking caused by the brain-wasting disease by 27 per cent Evening Standard · Sep 28, 2022
World's first EVER drug shown to work against Alzheimer's developed by scientists Scientists say the development of the only drug to work against Alzheimer’s is a 'historic moment' - with regulators expected to approve the groundbreaking drug by the New Year Daily Mirror · Sep 28, 2022
Major breakthrough for dementia and Alzheimer's as drug found to reduce decline Alzheimer’s Research UK said the finding was a “historic moment for dementia research” Wales Online · Sep 28, 2022
‘Major breakthrough’ as dementia drug found to ‘slow cognitive decline’ The new clinical trial found that there was a significant reduction in the decline in memory and thinking usually seen in early-stage patients. The Independent UK · Sep 28, 2022
Health: Study finds Alzheimer's disease risk connected to newly discovered protein According to a new USC study, a mutation in a newly discovered small protein is connected to a significant increase in the risk for Alzheimer's disease, expanding the known gene targets for the disease and presenting a new potential avenue for treatment. Read more on Dynamite News: Dynamite News · Sep 22, 2022
Daily Record · Sep 21, 2022 The simple steps to help prevent Alzheimer's and keep your brain active and healthy Here's some helpful advice if you are worried about dementia or are supporting a loved one who is suffering.
Benzinga · Sep 21, 2022 IGC Announces Issuance Of Second Patent For The Treatment Of Alzheimer's Using THC India Globalization Capital, Inc. (AMEX:IGC) announced that the United States Patent and Trademark Office issued a second patent (#11,446,276) for the treatment of Alzheimer’s disease entitled “Extreme low dose THC as a therapeutic and prophylactic agent for Alzheimer’s disease.”
The Conversation · Sep 19, 2022 Alzheimer’s might not be primarily a brain disease. A new theory suggests it’s an autoimmune condition. The pursuit of a cure for Alzheimer’s disease is becoming an increasingly competitive and contentious quest with recent years witnessing several important controversies.
The Guardian - UK · Sep 14, 2022 Daily multi-vitamins may improve brain function in older people – US study Trial finds supplements could slow decline by 60% but Alzheimer’s and dementia experts caution larger studies needed
WEKU · Sep 12, 2022 With early Alzheimer's in the family, these sisters decided to test for the gene For some people, a rare genetic mutation makes dementia inescapable. Three sisters have decided to confront fate with a genetic test and have joined a research project on possible treatments.
The Independent UK · Sep 9, 2022 People with ‘poor dental hygiene’ more likely to develop Alzheimer’s, study finds There is currently no cure for the progressive condition
Wales Online · Sep 6, 2022 Signs of Alzheimer's disease to look out for including mood swings, weight loss and sleep problems Alzheimer's disease is the most common form of dementia and the signs differ as it develops
Liverpool Echo · Sep 6, 2022 Alzheimer's Disease signs to look out for Alzheimer's disease is the most common form of dementia
The Conversation · Sep 6, 2022 A window to the brain: the retina gives away signs of Alzheimer's disease and could help with early detection The retina has long been poeticised as the window to the soul, but research now shows it could be a window to the brain and act as an early warning system for cognitive decline.
Inverse · Sep 4, 2022 Mice models for studying Alzheimer’s disease aren’t enough — here’s what will help A more complementary animal model, however, could help researchers better translate the results from animal studies to humans.
The Conversation · Aug 31, 2022 Expanding Alzheimer's research with primates could overcome the problem with treatments that show promise in mice but don't help humans As of 2022, an estimated 6.5 million Americans have Alzheimer’s disease, an illness that robs people of their memories, independence and personality, causing suffering to both patients and their families. That number may double by 2060. The U.S. has made considerable investments in Alzheimer’s research, having allocated US$3.5 billion in…